2 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Mridula George, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RADIANT: Pre-op Radiation With Abemaciclib and Letrozole Abemaciclib, Letrozole - Breast Cancer | Phase 1 | Recruiting | Mridula George, MD | 15 | 2024-08-22 | 2025-11-14 |
| OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer Combination of liposomal doxorubicin - Triple Negative Breast Cancer (TNBC) | Phase 2 | Active not recruiting | Mridula George, MD | 30 | 2023-10-07 | 2025-11-14 |
| INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study Pelareorep, Quality-of-Life Assessment, Questionnaire Administration - Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma | Phase 2 | Active not recruiting | Mridula George, MD | 25 | 2020-07-13 | 2025-04-04 |
Triple Negative Breast Neoplasms (2) · Breast Neoplasms (1)
Letrozole (1) · abemaciclib (1) · reolysin (1)
United States (3)
Mridula A George (1) · Mridula A George, MD (1)
P30CA072720 (1)